Stock CMND CLEARMIND MEDICINE INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Clearmind Medicine Inc. Canadian Securities Exchange

Equities

CMND

CA1850534027

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Clearmind Medicine Inc. Announces Advancement in its Proprietary MEAI- Based Binge Behaviors Treatment
CI
Clearmind Medicine Secures Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment
CI
Clearmind Medicine Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
CI
Clearmind Medicine Inc. Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product
CI
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment
CI
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
CI
Clearmind Medicine Inc. Announces International Patent Application for Preventing and Treating Depression
CI
Clearmind Medicine Inc. Receives Divisional Patent Approval by the China National Intellectual Property Administration
CI
Clearmind Medicine Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMND Stock
  4. CMND Stock
  5. News Clearmind Medicine Inc.
  6. Highlights